NBE-Therapeutics
VerifiedResearch in cancer treatment
Launch date
Employees
Ownership
Firm valuation
$1.3b (Dealroom.co estimates Dec 2020.)
Basel Canton of Basel-Stadt (HQ)
Financials
Edit| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | 5m | 4m | 4m | - | - | - | - |
| % growth | - | (20 %) | - | - | - | - | - |
Source: Company fillings or news article
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | Seed Not yet verified | ||
| €2.8m | Series A | ||
| €18.7m | Series B | ||
| €17.3m | Series B | ||
* | $22m | Series C | |
| €1.2b Valuation: €1.2b | Acquisition | ||
| Total Funding | $64.7m | ||
Recent News about NBE-Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.